Bleomycin 30 [USP'U]/1

Bleomycin 30 USP'U/1 is a lyophilized powder injection used for various medical purposes. This medication is manufactured by Hikma Pharmaceuticals USA Inc. and is available in a 1 vial pack size.

Bleomycin 30 USP'U/1 is commonly used for certain types of cancer treatments. It works by interfering with the growth of cancer cells, making it a key component in chemotherapy regimens. The specific uses of Bleomycin can vary, and it is often administered based on individual patient needs and medical protocols.

When administered, Bleomycin 30 USP'U/1 may cause various effects, including fatigue, nausea, and skin reactions. Some patients might experience more severe side effects, which should be discussed with a healthcare provider. The exact effects can vary depending on the individual and the specific treatment plan.

Bleomycin 30 USP'U/1 should be handled with care and stored as directed. It is important to follow the administration guidelines provided by a healthcare professional to ensure safety. Patients should be monitored for any adverse reactions and report them promptly.

Bleomycin 30 USP'U/1 may interact with other medications, including certain antibiotics and chemotherapy drugs. It is crucial to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect the efficacy and safety of Bleomycin.